David Skarinsky

Vice President of Clinical Operations

David Skarinsky currently serves as vice president of clinical operations for Zavante Therapeutics. Skarinsky brings more than 25 years of multinational development leadership experience, including project planning, risk management, clinical operations, global regulatory strategy and quality systems. Previously, Skarinsky was with PAREXEL International as senior director of project management and principal regulatory consultant where he led project teams in the areas of CNS, analgesia, endocrinology, immunology, gynecology, oncology and anti-virals. Previous to this, Skarinsky held senior operations and project management leadership roles at Hollis Eden Pharmaceuticals, Rhone-Poulenc Rorer, Sanofi-Aventis, Celltech-Medeva, Quintiles Pacific and Wyeth Ayerst. He has led teams supporting successful Phase III development for products such as Venlafaxine®, Rilutek®, CombiPatch®, Vivelle®/Menorest®, Arixtra® and Metadate ER® / IR®. Skarinsky holds a bachelor’s degree in neuroscience from Amherst College, is fluent in Russian and has a regulatory affairs U.S. certification (US-RAC).